🇺🇸 FDA
Patent

US 12240872

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 12240872 (Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same) held by Inovio Pharmaceuticals, Inc. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/55527